DGS Capital Management »

Regeneron Pharmaceuticals shares owned by DGS Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by DGS Capital Management from 13F filings

Historical chart of DGS Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by DGS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by DGS Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $362k 376 962.49
2023-12-31 $330k 376 878.29
2023-09-30 $310k 377 822.96
2023-06-30 $280k 389 718.54
2023-03-31 $333k 405 821.67
2022-12-31 $305k 422 721.49
2022-09-30 $343k 498 688.87
2022-06-30 $292k 494 591.09
2022-03-31 $295k 423 697.40
2021-12-31 $289k 458 631.00